New services expand remote biomonitoring and telehealth tools and include new personalized medication management
“Many high-risk patients have sought to avoid exposure to COVID-19 by forgoing needed treatments for their disease states, thereby exacerbating their conditions during self-isolation. That’s why, more than ever, home-based remote monitoring is going to be an essential component of care.”
To provide more personalized care for home-bound and high-risk patients, CommonSpirit Health at Home has expanded its virtual monitoring capabilities to better respond to patients’ needs during and beyond the COVID-19 pandemic. Serving 140,000 of CommonSpirit’s patients in 10 states, Health at Home fasttracked the launch of the telehealth tools not only to serve COVID-19 patients but also for high-risk patients who are self-isolating so they have access to biomonitoring capabilities and a delivery service that sends prearranged medications.
TO READ THE FULL ARTICLE…
This article is subscriber content and requires a subscription. If you have a subscription, then please Login here. If you do not have a subscription, you may purchase one below.